Drug recall · January 22, 2020
Tri-Lo-Marzia recall
Why: CGMP Deviations: Out of specification test result observed during retrospective review of blend uniformity test data.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Tri-Lo-Marzia (Norgestimate and Ethinyl Estradiol Tablets, USP), 0.180 mg/0.025 mg; 0.215mg/0.025 mg and 0.250 mg/0.025 mg, Pack size - 3 x 28's wallets/carton, Rx Only, Distributed by Lupin Pharmaceuticals, Inc, Baltimore MD 21202, Manufactured by: Lupin Limited, Pithampur, (M.P.)- 454775, India. NDC 68180-837-13 (3x28 carton ) NDC 68180-837-11 (28 tablet wallet)
- Lots / codes
Lot # L800498, exp. date February 2020
- Quantity
- 34,080 boxes (3 wallets per carton, 80 cartons per box)
- Company
- Lupin Pharmaceuticals Inc., Baltimore, MD
- Distribution
- Distributed nationwide in the US
- Initiated
- January 10, 2020 · Voluntary: Firm initiated
- Classified
- January 17, 2020
- Reported
- January 22, 2020
- Ended
- June 3, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ethinyl estradiol / norgestimate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.